Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06820216Completed
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Tanta University. Primary endpoint: Total postoperative opioid consumption in the first 24 hours after surgery. Started Feb 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06820216.